US 11780931
CD47 targeted therapies for the treatment of infectious disease
granted A61KA61K2039/505A61K38/1774
Quick answer
US patent 11780931 (CD47 targeted therapies for the treatment of infectious disease) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K2039/505, A61K38/1774, A61P, A61P31/12